Brimonidine Tartrate eent and Lanreotide Subcutaneous
Determining the interaction of Brimonidine Tartrate eent and Lanreotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine ophthalmic, Brimonidine (Ophthalmic)
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine Tartrate eent-Lansoprazole
- Brimonidine Tartrate eent-Lansoprazole Delayed-Release Capsules
- Brimonidine Tartrate eent-Lansoprazole Orally Disintegrating Tablets
- Brimonidine Tartrate eent-Lansoprazole, Amoxicillin, and Clarithromycin
- Brimonidine Tartrate eent-Lanthanum
- Brimonidine Tartrate eent-Lanthanum carbonate
- Lanreotide Subcutaneous-Brimonidine Tartrate topical
- Lanreotide Subcutaneous-Brimonidine topical
- Lanreotide Subcutaneous-Brimonidine Topical application
- Lanreotide Subcutaneous-Brintellix
- Lanreotide Subcutaneous-Brinzolamide
- Lanreotide Subcutaneous-Brinzolamide and Brimonidine